Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases

Background: Tongxinluo (TXL) capsule, a polypharmacy derived from traditional Chinese medicine (TCM), has been widely used in coronary heart disease (CHD), while the underlying mechanism of TXL capsule is still unclear. The present study aimed at investigating the underlying mechanism of TXL acting...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guode, Xu, Qingbo, Han, Kedong, Yan, Wenhe, Huang, Chaopei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cardiovascular System & Vascular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560518/
https://www.ncbi.nlm.nih.gov/pubmed/32990315
http://dx.doi.org/10.1042/BSR20201349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560518/
https://www.ncbi.nlm.nih.gov/pubmed/32990315
http://dx.doi.org/10.1042/BSR20201349

Ejemplares similares